Natural pharmaceutical composition for treating clinical cow mastitis and preparation method of natural pharmaceutical composition

Abstract

The invention discloses a natural pharmaceutical composition for treating clinical cow mastitis. The natural pharmaceutical composition is prepared from the following crude drugs in parts by weight: 200-500 parts of fructus kochiae, 200-500 polygala tenuifolia, 100-300 dandelion and 50-150 rhizoma cyperi. The invention further provides a preparation method of the natural pharmaceutical composition. The natural pharmaceutical composition has the beneficial effects of being reasonable in drug compatibility, good in drug stability, significant in curative effect, convenient to use and free of a drug residue, and does not easily generate the bacterial drug resistance.

Description

technical field [0001] The invention relates to the technical field of veterinary natural medicinal compositions, in particular to a natural medicinal composition for treating clinical cow mastitis and a preparation method thereof. Background technique [0002] Cow mastitis is a complex mammary gland disease, which is a syndrome including mammary gland infection, mammary gland inflammation, microcirculation and immune disorders. It is a common and frequently-occurring disease that occurs all over the world. It is one of the most important diseases that affect the development of the dairy industry. It not only affects the health of dairy cows, reduces milk production and quality, but also causes diseased cows to be eliminated or die. Causing huge economic losses to the dairy industry. According to reports, the incidence of mastitis in most countries in the world is about 40%, and the annual loss due to mastitis is as high as 35 billion US dollars. In my country, the incidenc...

AI Technical Summary

Problems solved by technology

At present, the treatment of dairy cow mastitis is still dominated by antibiotics. Due to repeated large-scale use, antibiotic residues in milk and the resistance of pathogenic bacteria are becoming more and more serious, which has seriously affected people's physical and mental health. The main obstacle to the development of the industry

Over the years, many scholars at home and abroad have conducted extensive research on the disease, but because of the wide variety of pathogenic microorganisms and the complexity of the pathogenic bacteria, especially for some chronic mastitis and mastitis caused by drug-resistant bacteria, only relying on antibiotics It is difficult to effectively and comprehensively control it through treatment. Therefore, the development of safe, green, effective and low-residue drugs has become a research hotspot at home and abroad.

Images